Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
An old influenza strain still circulating in birds and swine could easily jump back to humans now that immunity to it has dropped, warn Gary J. Nabel and his colleagues.
Most Europeans haven't heard of their nation's repositories of human blood and tissue samples. Promote them, say George Gaskell and Herbert Gottweis, or they could fail.
Two centuries on from the Luddite insurrection, David Edgerton celebrates today's most important opponents to new ideas, inventions and innovations: scientists.
Two views on whether scientists who believe that animal experimentation is necessary should become public advocates, or work quietly behind the scenes.
Will the $27-billion investment in electronic records in the United States revolutionize care and research, or will it be a missed opportunity for patients and science?
Most protein research focuses on those known before the human genome was mapped. Work on the slew discovered since, urge Aled M. Edwards and his colleagues.
Regulators, doctors and patients need to prepare for the ethical, legal and practical effects of sequencing fetal genomes from mothers' blood, says Henry T. Greely.
On the anniversary of Haiti's devastating quake, Nicholas Ambraseys and Roger Bilham calculate that 83% of all deaths from building collapse in earthquakes over the past 30 years occurred in countries that are anomalously corrupt.
The dismal patchwork of fragmented research on disease-associated biomarkers should be replaced by a coordinated 'big science' approach, argues George Poste.
More than ever before, new techniques show the bond to be a convenient fiction, albeit one that holds the field of chemistry together, finds Philip Ball.